CLEVELAND--(BUSINESS WIRE)--The ScottCare Corporation, a provider of devices, software and shared monitoring labor solutions to cardiology practices and hospitals for the effective management of cardiovascular disease, announces the recent introduction of TeleSense RCM, a three-in-one device incorporating complete mobile cardiac telemetry (MCT), Holter and cellular event monitoring. TeleSense is ideal for cardiology practices and hospitals seeking to easily and more effectively manage symptomatic and asymptomatic cardiac event patients.
With TeleSense, clinicians have the convenient flexibility to transition as needed among the three monitoring modes (MCT, Holter and event). The TeleSense features real-time streaming for live patient visibility, auto-detection of arrhythmia events and wireless transmission of three channels of ECG data, allowing clinicians to more accurately correlate patient symptoms to changes in electrical conduction of the heart. TeleSense can transmit up to 30 days of continuous ECG data across multiple cellular networks or utilizing a patient’s home or business WiFi network.
Events are received and triaged through ScottCare’s highly-tested and proven receiving platform. TeleSense’s web-accessible reporting software then supports detailed and actionable reporting through daily heart rate trends; event reports; end-of-session reports; interim and summary statistics; and advanced administrative and clinical queries. Optional EHR integration enables reports to be easily viewed and e-signed by the physician prior to automated transmission to any HL7-based electronic health record (EHR) system.
TeleSense also addresses the continuous concern of patient compliance. Not only is the TeleSense comfortable to wear, it is simple to set up and configure—the device can even be configured remotely. Brightly-lit icons allow the patient to easily identify whether the device has sufficient power, whether leads are properly connected, if the device is recording, and the status of the WiFi or cellular connection. Patients can quickly record and immediately transmit self-identified events via a large, easily accessible button on the front of the device.
“We created TeleSense with the goal of providing clinicians with an easy-to-use, comprehensive monitoring device they could trust for diagnostic accuracy, technological reliability and improved patient compliance. They can depend on TeleSense to help them care for their cardiac event patients in a highly convenient and effective way. We’re proud to have added TeleSense to our portfolio and know clinicians will be as well,” said Sneh Merchant, ScottCare’s vice president of research and development.
For those clinicians unable to offer patients 24-hour monitoring coverage, ScottCare’s optional dedicated monitoring labor service provides 24/7 active daily surveillance and reporting capabilities, as well as immediate access to raw patient data and completed reports from any internet connected computer.
About The ScottCare Corporation
ScottCare provides hospitals, cardiology practices and independent testing facilities worldwide with monitoring devices, software, labor services and EHR data integration to aid in the diagnosis and management of cardiovascular disease. Solutions include those for diagnostic monitoring, CIED patient data management and cardiopulmonary rehabilitation. ScottCare also provides contracted ambulatory ECG and remote CIED device monitoring services for cardiologists and hospitals through its Ambucor division (www.scottcare.com/ambucor). Based in Cleveland, Ohio, ScottCare is a subsidiary of The Scott Fetzer Company (a wholly owned subsidiary of Berkshire Hathaway), a diversified manufacturer and marketer of high quality products for the home, family and industry comprising more than 20 businesses. To learn more, visit www.scottcare.com.
